CDP-Choline (Citicoline) vs Fasoracetam

Mechanism

Prodrug that is hydrolyzed to choline and cytidine upon oral ingestion. Choline supports acetylcholine synthesis and phosphatidylcholine membrane repair. Cytidine is converted to uridine, which enhances synaptic membrane synthesis via the Kennedy pathway and upregulates dopamine receptor density. This dual mechanism — cholinergic support plus dopaminergic modulation — is unique among choline sources.

Standard Dosing

250-500 mg/day

Timing

Morning or split morning/afternoon. With or without food.

Cycle Duration

Ongoing; no cycling required

Side Effects

• GI distress
• Headache
• Insomnia (due to dopaminergic activity)
• Diarrhea at high doses

Contraindications

• Known hypersensitivity to citicoline

Best Stacking Partners

Mechanism

Non-classical racetam that modulates all three groups of metabotropic glutamate receptors (mGluR Groups I, II, and III) and upregulates GABA-B receptors — a unique mechanism that distinguishes it from other racetams. Also enhances high-affinity choline uptake (HACU) and stimulates acetylcholine release. Does not significantly affect adrenergic, serotonergic, or dopaminergic receptors. The GABA-B upregulation is particularly notable as it may counteract GABA-B receptor downregulation caused by phenibut or baclofen tolerance.

Standard Dosing

20-100 mg 1-3 times daily (sublingual or oral)

Timing

Morning and afternoon. Sublingual administration may provide faster onset and higher bioavailability. With or without food.

Cycle Duration

Cycles of 4-8 weeks on, 2-4 weeks off. Limited long-term safety data.

Side Effects

• Headache
• Fatigue
• GI discomfort
• Irritability
• Brain fog (paradoxical, at excessive doses)

Contraindications

• Known hypersensitivity to racetams
• Pregnancy and lactation (no safety data)
• Severe renal or hepatic impairment

Best Stacking Partners